HER2 Support Group Forums - View Single Post - Trastuzumab-dm1

runtolive · 01-28-2008, 12:02 PM

current phase 1 sites.
The phase I study for trastuzumab-DM1is located at the following institutions:

<LI class=MsoNormal style="COLOR: navy; mso-list: l1 level1 lfo3">Dr. Howard Burris at Sarah Cannon Research Cancer Institute, Nashville. E-mail: hburris@tnonc.com <LI class=MsoNormal style="COLOR: navy; mso-list: l1 level1 lfo3">Dr. Monica Mita at Institute for Drug Development, San Antonio. E-mail: mmita@idd.org <LI class=MsoNormal style="COLOR: navy; mso-list: l1 level1 lfo3">Dr. Ian Krop at Dana Farber Cancer Institute, Boston. E-mail: ikrop@partners.org
Dr. Shanu Modi at Memorial Sloan-Kettering Cancer Center. E-mail: modis@mskcc.org

01-28-2008, 12:02 PM	#2
runtolive Senior Member Join Date: Nov 2007 Posts: 210	current phase 1 sites. The phase I study for trastuzumab-DM1is located at the following institutions: <LI class=MsoNormal style="COLOR: navy; mso-list: l1 level1 lfo3">Dr. Howard Burris at Sarah Cannon Research Cancer Institute, Nashville. E-mail: hburris@tnonc.com <LI class=MsoNormal style="COLOR: navy; mso-list: l1 level1 lfo3">Dr. Monica Mita at Institute for Drug Development, San Antonio. E-mail: mmita@idd.org <LI class=MsoNormal style="COLOR: navy; mso-list: l1 level1 lfo3">Dr. Ian Krop at Dana Farber Cancer Institute, Boston. E-mail: ikrop@partners.org Dr. Shanu Modi at Memorial Sloan-Kettering Cancer Center. E-mail: modis@mskcc.org